Standard News

Hide Advertisement
  • Business
  • Culture
  • News
  • Technology
  • Trending
Site logo
ADVERTISEMENT
ADVERTISEMENT

Mylan CEO to testify before House panel over EpiPen pricing

By Reuters 2 min read
Advertisement - Continue reading below
A file photo showing the EpiPen auto-injection epinephrine pens manufactured by Mylan NV pharmaceutical company are seen in Washington

WASHINGTON (Reuters) – Mylan NL Chief Executive Officer Heather Bresch will appear at a Sept. 21 congressional hearing over price increases for its EpiPen emergency allergy treatment, the U.S. House of Representatives Oversight Committee said in a statement on Wednesday.

Mylan has been widely criticized, including by U.S. Democratic presidential candidate Hillary Clinton, for sharply raising the price of EpiPens, which are carried by people with life-threatening allergies.

Advertisement

Mylan, which acquired the product in 2007, recently raised the list price for a pair of EpiPen auto-injectors to $600. The price has been rising from a cost of about $100 in 2008.

Mylan spokeswoman Nina Devlin confirmed that Bresch will attend the hearing.

“Heather is very good at being able to give an answer without offering much information,” said Evercore ISI analyst Umer Raffat, adding that he will be watching for any other issues that might be raised by the Committee.

A probe into EpiPen pricing by a U.S. Senate subcommittee was announced on Sept. 7.

Bresch is the daughter of U.S. Senator Joe Manchin, a Democrat from West Virginia.

The House panel co-chairmen, Republican Representative Jason Chaffetz and Democratic Representative Elijah Cummings, noted there is “… justified outrage from families and schools across the country struggling to afford the high cost of EpiPens.”

The committee planned to look at how to spur competition in the EpiPen market and speed approval by the Food and Drug Administration (FDA) of generic alternatives, according to the statement.

In response to the furor, Mylan last month said it would sell its own generic version of EpiPen for $300.

Teva Pharmaceutical Industries, which for years has been working on developing a generic alternative to EpiPen, said last week that it hopes to gain U.S. approval by late 2017 or early 20018.

EpiPen, which has annual sales of about $1 billion, delivers a potentially life-saving dose of epinephrine by injection into the thigh to counter dangerous allergic reactions, including to peanuts and bee stings. Mylan owns 94 percent of the market for such auto-injected devices.

The committee said it also planned to call as a witness Dr Doug Throckmorton, the FDA’s deputy director at the Center for Drug Evaluation and Research.

(Reporting by Eric Walsh and Susan Heavey in Washington and Bill Berkrot in New York; Editing by Chizu Nomiyama, Bernard Orr)

tagreuters.com2016binary_LYNXNPEC8D0ST-VIEWIMAGE

Advertisement - Continue reading below

Families remember 9/11 victims 15 years after attacks
News
Reuters 4 min read

Families remember 9/11 victims 15 years after attacks

U.S. Navy identifies Blue Angel pilot who died in crash
News
Reuters 1 min read

U.S. Navy identifies Blue Angel pilot who died in crash

Former College Shows Exactly How Scary School Can Be
Entertainment
David Clarke 3 min read

Former College Shows Exactly How Scary School Can Be

The 25 Most Innovative Company Product Strategies, As Shared By TikTok
Lifestyle
Ethan Blake 4 min read

The 25 Most Innovative Company Product Strategies, As Shared By TikTok

Sandusky is innocent, deserves new trial, lawyer says
News
Reuters 2 min read

Sandusky is innocent, deserves new trial, lawyer says

8 Professional Tips to Help You Organize Your Kitchen Like a Chef
Lifestyle
Ethan Blake 6 min read

8 Professional Tips to Help You Organize Your Kitchen Like a Chef

7-Eleven worker becomes first woman to climb Everest seven times
News
Reuters 1 min read

7-Eleven worker becomes first woman to climb Everest seven times

Accelerating Jobs Growth Gives Fed License to Tighten Interest Rates Faster in 2017
Business
Jason Owen 2 min read

Accelerating Jobs Growth Gives Fed License to Tighten Interest Rates Faster in 2017

South Dakota motorcycle rally gets back to normal after big 2015
News
Reuters 2 min read

South Dakota motorcycle rally gets back to normal after big 2015

Southwest Airlines halts flights after technical outage
News
Reuters 2 min read

Southwest Airlines halts flights after technical outage

load more Loading posts...

sidebar

ADVERTISEMENT
ADVERTISEMENT

sidebar-alt

  • About Us
  • Imprint
  • Contact Us
  • Terms of Service
  • Privacy Policy
  • For Advertisers